BEOVU

Product NDC
0078-0827
11-digit product format
000780827
Labeler code
0078
Product ID
0078-0827_8b8e71f4-7d7e-40b5-a942-89ac3b6c0c6c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
brolucizumab
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Labeler
Novartis Pharmaceuticals Corporation
Application
BLA761125
Marketing category
BLA
Marketing start
2019-10-07
Substance
BROLUCIZUMAB
Active strength
6 mg/.05mL
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0078-08270078-0827-61DDiscontinued by firm2026-08-03
excluded packagepackage0078-08270078-0827-99DDiscontinued by firm2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source datePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-050078-0827-99d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-050078-0827-61d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-260078-0827-99f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-260078-0827-61f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-310078-0827-992ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-310078-0827-612ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-280078-0827-99a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-280078-0827-61a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-210078-0827-99cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-210078-0827-61cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-100078-0827-99cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-100078-0827-61cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-310078-0827-99302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-310078-0827-61302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-200078-0827-99ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-200078-0827-61ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100078-0827-990efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-100078-0827-610efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-080078-0827-99ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-080078-0827-61ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-030078-0827-61367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-030078-0827-99367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-090078-0827-99557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-090078-0827-61557ba5c1ecfa…9c80585c8c6e…

Additional Listing Data#

Finished product
Yes
Brand name base
BEOVU
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BROLUCIZUMAB6 mg/.05mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
XSZ53G39H5Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2204920Internal RxNorm lookup
2204925Internal RxNorm lookup
2602276Internal RxNorm lookup
2602279Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3dAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cb9fb3d0-13ff-4090-b463-8897d95f90faProduct name120200305

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0078-0827-60BEOVU0.05 mL in 1 SYRINGE, GLASSINJECTION, SOLUTION0.0516
0078-0827-60BEOVU1 in 1 CARTONINJECTION, SOLUTION116
0078-0827-61BEOVU1 in 1 CARTONINJECTION, SOLUTION116
0078-0827-61BEOVU0.05 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION0.0516
0078-0827-98BEOVU1 in 1 CARTONINJECTION, SOLUTION116
0078-0827-98BEOVU0.05 mL in 1 SYRINGE, GLASSINJECTION, SOLUTION0.0516
0078-0827-99BEOVU1 in 1 CARTONINJECTION, SOLUTION116
0078-0827-99BEOVU0.05 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION0.0516

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0078-0827-60ML - Milliliter0078-0827283dea16-4acc-43d2-a9fb-e698155c290f12022-06-06
0078-0827-61ML - Milliliter0078-082751c21738-2e6c-46d0-b1e5-55dc7133334b12019-11-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0078-0827BEOVU (BROLUCIZUMAB) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION]15Current NDC, Legacy NDC, 8 package rows20250226_5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BEOVUBROLUCIZUMABNovartis Pharmaceuticals Corporation5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d2025-11-03Warnings, Adverse reactionsExact identifier
application number: BLA761125
ndc (product): 0078-0827

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761125Beovubrolucizumab-dbll351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2204925Beovu 6 MG in 0.05 ML InjectionPSN5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2602279Beovu 6 MG in 0.05 ML Prefilled SyringePSN5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2204920brolucizumab-dbll 6 MG in 0.05 ML InjectionPSN5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2602276brolucizumab-dbll 6 MG in 0.05 ML Prefilled SyringePSN5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
22049250.05 ML brolucizumab-dbll 120 MG/ML Injection [Beovu]SBD5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
26022790.05 ML brolucizumab-dbll 120 MG/ML Prefilled Syringe [Beovu]SBD5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
22049200.05 ML brolucizumab-dbll 120 MG/ML InjectionSCD5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
26022760.05 ML brolucizumab-dbll 120 MG/ML Prefilled SyringeSCD5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2204925Beovu 120 MG/ML per 0.05 ML InjectionSY5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2602279Beovu 120 MG/ML per 0.05 ML Prefilled SyringeSY5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2204925Beovu 6 MG per 0.05 ML InjectionSY5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2602279Beovu 6 MG per 0.05 ML Prefilled SyringeSY5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2204920brolucizumab-dbll 120 MG/ML per 0.05 ML InjectionSY5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2602276brolucizumab-dbll 120 MG/ML per 0.05 ML Prefilled SyringeSY5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2204920brolucizumab-dbll 6 MG per 0.05 ML InjectionSY5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16
2602276brolucizumab-dbll 6 MG per 0.05 ML Prefilled SyringeSY5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d16

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0078-0827-60000780827601 SYRINGE, GLASS in 1 CARTON (0078-0827-60) / .05 mL in 1 SYRINGE, GLASS2022-03-090000-00-00NoNoCurrent
0078-0827-61000780827611 VIAL, SINGLE-DOSE in 1 CARTON (0078-0827-61) > .05 mL in 1 VIAL, SINGLE-DOSE2019-10-070000-00-00NoNoCurrent
0078-0827-98000780827981 SYRINGE, GLASS in 1 CARTON (0078-0827-98) / .05 mL in 1 SYRINGE, GLASS2022-03-090000-00-00YesNoCurrent
0078-0827-99000780827991 VIAL, SINGLE-DOSE in 1 CARTON (0078-0827-99) > .05 mL in 1 VIAL, SINGLE-DOSE2019-10-070000-00-00YesNoCurrent